SRC is also involved in mediating MM cell migration and invasion induced by high cell surface levels of CD26/dipeptidyl peptidase 4 (DPP4) [46], a transmembrane glycoprotein, which has been suggested as a potential therapeutic target against MM [96]. Here, SRC is linked to Miyoshi myopathy.